Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00711451 · ClinicalTrials.gov registry record · NA
Manual and Expressed Placental Removal at Cesarean Delivery and Its Effects on Various Cardiac Indices
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00711451 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 19 participants.
The verdict
NCT00711451, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether manual removal of the placenta during a cesarean delivery results in higher changes in the resistance of blood flow throughout the body, also called systemic vascular resistance (SVR)
Interventions
- BEHAVIORAL Manual removal
- PROCEDURE Expressed removal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00711451
The ClinicalTrials.gov registry entry for NCT00711451 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Manual removal is the first listed.
NCT00711451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00711451 about?
NCT00711451 is a clinical study titled "Manual and Expressed Placental Removal at Cesarean Delivery and Its Effects on Various Cardiac Indices". The purpose of this study is to evaluate whether manual removal of the placenta during a cesarean delivery results in higher changes in the resistance of blood flow throughout the body, also called systemic vascular resistance (SVR)
What is the current status of trial NCT00711451?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2008-07. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00711451?
The interventions under investigation include: Manual removal (BEHAVIORAL), Expressed removal (PROCEDURE).
Who is sponsoring clinical trial NCT00711451?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.